2022
DOI: 10.3389/fmedt.2022.952767
|View full text |Cite
|
Sign up to set email alerts
|

Review of investigational medical devices' clinical trials and regulations in Africa as a benchmark for new innovations

Abstract: Medical technologies present a huge potential in improving global health playing a key role toward achieving Sustainable Development Goal 3 by 2030. A number of clinicians, innovators, business entities and biomedical engineers among others have developed a number of innovative medical devices and technologies to address the healthcare challenges especially in Africa. Globally, medical devices clinical trials present the most acceptable method for determining the risks and benefits of medical device innovation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 46 publications
0
1
0
Order By: Relevance
“…Moreover, few of these trials are locally initiated, and most are sponsored and led by foreign research organizations. The barriers to conducting clinical trials in Sub Saharan African (SSA) countries include complicated logistical systems, inadequate funding, slow regulatory and ethical approval procedures, and poor infrastructure among others ( 22 , 23 ). The existing inefficiencies in regulatory practices and policies, and lack of infrastructure and facilities lead to high costs for trials, increased participant burden, lengthy and poorly defined clinical trial timelines ( 24 ).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, few of these trials are locally initiated, and most are sponsored and led by foreign research organizations. The barriers to conducting clinical trials in Sub Saharan African (SSA) countries include complicated logistical systems, inadequate funding, slow regulatory and ethical approval procedures, and poor infrastructure among others ( 22 , 23 ). The existing inefficiencies in regulatory practices and policies, and lack of infrastructure and facilities lead to high costs for trials, increased participant burden, lengthy and poorly defined clinical trial timelines ( 24 ).…”
Section: Introductionmentioning
confidence: 99%
“…The scarcity of medical device clinical trials in Africa is indicative of the challenges in developing and regulating medical devices within the continent. This gap in clinical trials is a significant barrier to ascertaining the effectiveness and safety of medical devices in the African context (Matovu et al, 2022).…”
Section: Comparative Analysis Of Medical Device Regulations: Usa Vs A...mentioning
confidence: 99%

Nzubechukwu Chukwudum Ohalete

Oluwatoyin Ayo-Farai,
Chinyere Onwumere,
Chinedu Paschal Maduka
et al. 2024
World J. Adv. Res. Rev.